Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,45 USD | +5,60 % | +10,61 % | -28,89 % |
Resumen de negocios
Número de empleados: 330
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cell and Gene Therapies
100,0
%
| 130 | 100,0 % | 65 | 100,0 % | -50,42 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 130 | 100,0 % | 65 | 100,0 % | -50,42 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01/04/23 |
Johanna Mylet
DFI | Director of Finance/CFO | 37 | 01/06/15 |
Mark Gergen
CHM | Chairman | 61 | 01/02/18 |
Loren Wagner
COO | Chief Operating Officer | - | 01/03/21 |
Chief Tech/Sci/R&D Officer | - | - | |
Kristin Martin
ADM | Chief Administrative Officer | 49 | 01/01/19 |
Harry Leonhardt
CMP | Compliance Officer | 67 | 16/07/20 |
Sarah Thailing
IRO | Public Communications Contact | - | 01/11/20 |
Lisa Portale
LAW | General Counsel | - | 01/01/19 |
Karen Basbaum
PRN | Corporate Officer/Principal | - | 01/07/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marcea Lloyd
BRD | Director/Board Member | 75 | 01/01/19 |
Cynthia Collins
BRD | Director/Board Member | 65 | 23/07/21 |
Mark Gergen
CHM | Chairman | 61 | 01/02/18 |
John Schmid
BRD | Director/Board Member | 60 | 19/07/18 |
Charles Baum
BRD | Director/Board Member | 65 | 16/05/22 |
Rafael Amado
BRD | Director/Board Member | 60 | 13/04/23 |
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01/04/23 |
Luke Corning
BRD | Director/Board Member | 41 | 16/12/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 96 928 203 | 63 621 281 ( 65,64 %) | 0 | 65,64 % |
Información de la empresa
Poseida Therapeutics, Inc.
9390 Towne Centre Drive Suite 200
92121, San Diego
+858 779 3100
http://www.poseida.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-28,89 % | 225 M | |
-3,04 % | 102 mil M | |
+1,98 % | 96,29 mil M | |
+2,13 % | 22,18 mil M | |
-15,30 % | 21,2 mil M | |
-9,21 % | 18,31 mil M | |
-39,98 % | 17,38 mil M | |
-15,11 % | 16,36 mil M | |
+5,46 % | 13,97 mil M | |
+33,36 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción PSTX
- Empresa Poseida Therapeutics, Inc.